Aflac outlines consensus picture, shares anchored in the S&P 500 insurance sector

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-30, 09:57.

Aflac Inc. (US0010551028) sits in the U.S. insurance segment with a long-standing listing on the NYSE as part of the S&P 500. The Tuesday focus today is on the analyst consensus around the shares and the established view on earnings and dividends from the coverage universe.

What the consensus shows today

Analysts typically frame Aflac as a supplemental health and life insurer with a mature U.S. and Japan footprint, which influences their earnings and valuation models. Coverage clusters around major U.S. brokerages and international research houses that monitor the wider insurance group.

The consensus view normally aggregates expectations for net earned premiums, operating earnings per share, and capital returns via buybacks and dividends. Houses such as Goldman Sachs, JPMorgan, Morgan Stanley, and regional institutions track these metrics in comparison with peers in the S&P 500 insurance cohort.

How Aflac fits in the peer group

Aflac is compared with life and health insurers and diversified financials, where U.S.-listed peers like MetLife and Prudential often serve as reference points for margin and capital adequacy. This peer framework feeds into the distribution of ratings from Buy to Hold across the coverage.

Dividend stability and recurring share repurchases play into valuation discussions, with analysts weighing payout ratios and surplus capital against regulatory and economic conditions. Aflac’s position as a long-established brand in supplemental coverage is part of the narrative.

The business behind the stock

Aflac generates most of its revenue from supplemental health insurance and life insurance policies sold to individuals and employers, notably in the U.S. and Japan. The company’s product mix includes cancer coverage, accident insurance, and hospital indemnity offerings with recurring premium streams.

Where the stock trades today

The Aflac shares (US0010551028) trade on the NYSE, with the latest indicative price in U.S. dollars reflecting the company’s position within the S&P 500 insurance segment as of 2026-06-30, 09:57.

Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation to engage in any securities transaction. All data points and descriptions reflect the latest generally accessible information at the time of review and may change without notice.